Cargando…
BRAF inhibition protects against hearing loss in mice
Hearing loss caused by noise, aging, antibiotics, and chemotherapy affects 10% of the world population, yet there are no Food and Drug Administration (FDA)-approved drugs to prevent it. Here, we screened 162 small-molecule kinase-specific inhibitors for reduction of cisplatin toxicity in an inner ea...
Autores principales: | Ingersoll, Matthew A., Malloy, Emma A., Caster, Lauryn E., Holland, Eva M., Xu, Zhenhang, Zallocchi, Marisa, Currier, Duane, Liu, Huizhan, He, David Z.Z., Min, Jaeki, Chen, Taosheng, Zuo, Jian, Teitz, Tal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821884/ https://www.ncbi.nlm.nih.gov/pubmed/33268358 http://dx.doi.org/10.1126/sciadv.abd0561 |
Ejemplares similares
-
Characterization of quinoxaline derivatives for protection against iatrogenically induced hearing loss
por: Zallocchi, Marisa, et al.
Publicado: (2021) -
CDK2 inhibitors as candidate therapeutics for cisplatin- and noise-induced hearing loss
por: Teitz, Tal, et al.
Publicado: (2018) -
ERK1/2 Inhibition Alleviates Noise-Induced Hearing Loss While Tempering Down the Immune Response
por: Lutze, Richard D., et al.
Publicado: (2023) -
Progress in the
Development of Preventative Drugs
for Cisplatin-Induced Hearing Loss: Miniperspective
por: Hazlitt, Robert A., et al.
Publicado: (2018) -
Quinoxaline protects zebrafish lateral line hair cells from cisplatin and aminoglycosides damage
por: Rocha-Sanchez, Sonia M., et al.
Publicado: (2018)